FdaApplication
NDA 012193
Identifiers
- fda_app_no: NDA012193
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SER-AP-ES | HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE | 25MG;15MG;0.1MG | TABLET;ORAL |
1 product